Christy J. Oliger

Insider Reports History

Location
Newton, MA
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christy J. Oliger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director Class A Common Stock 3,971 $264,945 $66.72 18 Jun 2025 Direct
Vera Therapeutics, Inc. Director Class A Common Stock 2,987 $128,528 $43.03 07 Jun 2024 Direct
LAVA Therapeutics NV Director Common Shares (Right to Buy) 33,390 13 Feb 2025 Direct
Replimune Group, Inc. Director Stock Option (right to buy) 32,000 01 Apr 2025 Direct
Vera Therapeutics, Inc. Director Stock Option (right to buy) 14,000 14 May 2025 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 6,119 18 Jun 2025 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 4,600 28 May 2025 Direct
LAVA Therapeutics NV Director Share Options (Right to Buy) 0 13 Nov 2025 Direct
RayzeBio, Inc. Director Employee Stock Option (Right to Buy) 0 26 Feb 2024 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 $73.68 26 Sep 2023 Direct
Sierra Oncology, Inc. Director Stock Option (right to buy) 0 01 Jul 2022 Direct

Insider Reports Filed by Christy J. Oliger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LVTX LAVA Therapeutics NV 13 Nov 2025 1 $0 4 Director 17 Nov 2025, 16:30
NUVL Nuvalent, Inc. 18 Jun 2025 2 $0 4 Director 20 Jun 2025, 16:32
NUVL Nuvalent, Inc. 18 Jun 2025 0 $0 3 Director 20 Jun 2025, 16:31
KPTI Karyopharm Therapeutics Inc. 28 May 2025 1 $0 4 Director 29 May 2025, 16:12
VERA Vera Therapeutics, Inc. 14 May 2025 1 $0 4 Director 16 May 2025, 16:12
REPL Replimune Group, Inc. 01 Apr 2025 1 $0 4 Director 03 Apr 2025, 20:00
LVTX LAVA Therapeutics NV 13 Feb 2025 1 $0 4 Director 18 Feb 2025, 20:15
LVTX LAVA Therapeutics NV 01 Jan 2025 0 $0 3 Director 02 Jan 2025, 09:32
VERA Vera Therapeutics, Inc. 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:16
VERA Vera Therapeutics, Inc. 07 Jun 2024 0 $0 3 Director 11 Jun 2024, 16:15
KPTI Karyopharm Therapeutics Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 17:32
REPL Replimune Group, Inc. 01 Apr 2024 1 $0 4 Director 03 Apr 2024, 20:00
/report/000141588924005551-oliger-christy-j-2024-02-26 RayzeBio, Inc. 26 Feb 2024 1 $0 4 Director 27 Feb 2024, 17:14
/report/000089924323019544-oliger-christy-j-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 8 $0 4 Director 26 Sep 2023, 17:30
/report/000120919123049506-oliger-christy-j-2023-09-14 RayzeBio, Inc. 14 Sep 2023 0 $0 3 Director 14 Sep 2023, 20:28
/report/000120919123035850-oliger-christy-j-2023-06-07 REATA PHARMACEUTICALS INC 07 Jun 2023 2 +$157,452 4 Director 09 Jun 2023, 16:24
KPTI Karyopharm Therapeutics Inc. 24 May 2023 1 $0 4 Director 25 May 2023, 16:09
REPL Replimune Group, Inc. 01 Apr 2023 1 $0 4 Director 04 Apr 2023, 20:02
/report/000120919122040232-oliger-christy-j-2022-07-01 Sierra Oncology, Inc. 01 Jul 2022 1 $0 4 Director 01 Jul 2022, 16:27
/report/000120919122035418-oliger-christy-j-2022-06-08 REATA PHARMACEUTICALS INC 08 Jun 2022 2 +$134,973 4 Director 09 Jun 2022, 16:42
KPTI Karyopharm Therapeutics Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 16:09
REPL Replimune Group, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:07
REPL Replimune Group, Inc. 01 Dec 2021 1 $0 4 Director 03 Dec 2021, 20:02
REPL Replimune Group, Inc. 01 Dec 2021 0 $0 3 Director 03 Dec 2021, 20:00
/report/000120919121040140-oliger-christy-j-2021-06-10 REATA PHARMACEUTICALS INC 10 Jun 2021 2 +$14,983 4 Director 14 Jun 2021, 11:29
/report/000120919121038155-oliger-christy-j-2021-06-02 Sierra Oncology, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 13:59
/report/000120919121038154-oliger-christy-j-2021-06-02 Sierra Oncology, Inc. 02 Jun 2021 0 $0 3 Director 04 Jun 2021, 13:55
KPTI Karyopharm Therapeutics Inc. 21 May 2021 1 $0 4 Director 21 May 2021, 17:35